HBOT is FDA-approved for the following uses: air or gas embolism, carbon monoxide poisoning, enhancement of healing in diabetically derived illness, exceptional blood loss (anemia), intracranial abscess, clostridial myositis and myonecrosis (gangrene), crush injury, compartment syndrome, decompression sickness, necrotizing soft tissue infections, osteomyelitis (refractory), delayed radiation injury, skin grafts and flaps, thermal burns, actinomycosis, cyanide poisoning, and delayed radiation injury.
HBOT is not FDA-approved for treatment of conditions like autism, multiple sclerosis, spinal injury, depression, Alzheimer's or stroke.
However, the absence of an FDA-endorsement does not mean HBOT cannot produce a beneficial outcome for individuals living with these conditions.
HBOT should not be considered a complete treatment plan without a medical prescription and consultation, but the addition of hyperbaric therapy in treatment of non-FDA approved conditions has advanced physical progress in thousands of individuals.